Bronchogen
Respiratory tract bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, slight swelling, or minor discomfort at the injection site may occur. Usually resolves within 1-2 hours. Ensure proper site rotation and sterile injection technique to minimize risk.
Although rare, allergic reactions including rash, itching, swelling of face/throat, or difficulty breathing require immediate medical attention. Discontinue use and seek emergency care if severe symptoms develop.
Mild headache has been reported in some users, typically resolving within hours. Ensure adequate hydration and consider timing of injection if headaches persist.
Occasional mild nausea or digestive changes have been reported. Usually transient and self-resolving. Take with food if gastrointestinal symptoms occur.
Rare reports of transient dizziness. Sit or lie down if this occurs. Ensure adequate hydration and food intake before injection.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mcg |
| Frequency | 1x daily |
| Timing | Morning, sublingual or subcutaneous |
| Route | Subcutaneous |
Khavinson bioregulator peptide. Widely used in Russia and Eastern Europe. Limited Western clinical trials. Start at lower end (10 mcg) and assess response before increasing. For research purposes only.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
Bronchogen is a short-chain peptide bioregulator from the Khavinson series designed to support respiratory tract tissue function and gene expression. It is theorized to work through tissue-specific signaling mechanisms that promote healthy epithelial cell function, support natural repair processes, and maintain homeostasis in the respiratory system. The exact molecular mechanism in humans remains incompletely characterized in published Western literature.
Tissue-Specific Gene Expression Regulation
Khavinson bioregulators are proposed to modulate gene expression in target tissues through peptide-receptor interactions, potentially influencing cellular differentiation and tissue-specific protein synthesis in respiratory epithelial cells
Cellular Homeostasis and Repair
Short peptides may support normal cellular maintenance and regeneration processes in damaged or aging respiratory tissue, promoting restoration of normal epithelial barrier function
Immune Modulation in Respiratory Tissue
Bioregulator peptides may support balanced immune responses in the respiratory tract, potentially enhancing local defense mechanisms without promoting excessive inflammation
- Bronchogen is a short peptide (2-4 amino acids) from the Khavinson bioregulator family, originally developed in Russia
- Khavinson bioregulators are proposed to work through tissue-specific mechanisms rather than systemic hormonal pathways
- Limited peer-reviewed Western clinical data exists; most evidence comes from Russian-language publications and clinical use in Eastern Europe
- The exact amino acid sequence and molecular mechanism in humans have not been fully published in accessible Western literature
Track your Bronchogen research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Bronchogen is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.